Factors influencing the interim interpretation of a breast cancer trial: Danger of achieving the “expected” result
- 1 June 1981
- journal article
- research article
- Published by Elsevier in Controlled Clinical Trials
- Vol. 2 (2) , 123-132
- https://doi.org/10.1016/0197-2456(81)90003-9
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Reporting standards and research strategies for controlled trialsControlled Clinical Trials, 1980
- Chemotherapy in advanced breast cancerInternational Journal of Radiation Oncology*Biology*Physics, 1978
- Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examplesBritish Journal of Cancer, 1977
- Systemic Therapy for Metastatic Breast CancerAnnals of Internal Medicine, 1977
- Combination chemotherapy for metastatic breast carcinoma.Prospective comparison of multiple drug therapy with L-phenylalanine mustardCancer, 1976
- Integration of chemotherapy into combined modality treatment of solid tumors: VII. Adenocarcinoma of the breastCancer Treatment Reviews, 1976
- COMBINATION VERSUS SEQUENTIAL 5-DRUG CHEMOTHERAPY IN METASTATIC CARCINOMA OF BREAST1976
- Chemotherapy of advanced breast cancer: a controlled randomized trial of cyclophosphamide versus a four-drug combinationBritish Journal of Cancer, 1975
- Evaluation of combination vs. sequential cytotoxic chemotherapy in the treatment of advanced breast cancerCancer, 1974
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958